The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

November 21, 2019

Study Completion Date

November 21, 2019

Conditions
Type 1 Diabetes MellitusCognitive Change
Interventions
DEVICE

SAP

Subjects will wear their own personal insulin pump and will wear the study CGM (Dexcom G6).

DEVICE

CLC

The Tandem t:slim X2 is an insulin pump with software (Control-IQ Technology) that helps regulate blood glucose more optimally, based on data received from the Dexcom G6 CGM.

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

Virginia Research Investment Fund

OTHER

collaborator

DexCom, Inc.

INDUSTRY

collaborator

Tandem Diabetes Care, Inc.

INDUSTRY

lead

University of Virginia

OTHER

NCT03674281 - The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System | Biotech Hunter | Biotech Hunter